Table 1.
Summary of current literature on treatment of liver malignancies using microwave ablation systems.
| Number of Patients |
Type of Tumor |
Follow-Up Time (months) |
Tumor Size (range) |
LTP Rate | Overall Survival Rates | Major Complication Rate |
|||
|---|---|---|---|---|---|---|---|---|---|
| Title (Year) | 1-year | 3-year | 5-year | ||||||
| Liang et al. (2007) | 1,007 | HCC | 17.3 (3.0-68.9) | 2.9 (1.0-18.5) | 5.9% | 91.2 | 72.5 | 59.8 | 2.2% |
| Swan et al. (2013) | 54 | HCC | 11.0 (1.0-33.0) | 2.5 (0.5-8.5) | 5.2% | 72.8 | 58.8 | - | 7.8% |
| Shi et al (2014) | 117 | HCC | 37.9 (4.0-99.0) | 3.0 (1.0-5.0) | 10.2% | 94 | 70 | 52 | - |
| Groeschl et al. (2014) | 139 | HCC | 18.0 (9.0-30.0) | 2.6 (0.7-6.0) | 9.6% | - | 38 | 19 | - |
| Ziemlewicz et al. (2015) | 75 | HCC | 14.0 (1.0-28.0) | 2.5 (0.5-7.0) | 6.6% | 76 | - | - | 0.0% |
| Zhang et al. (2015) | 45 | HCC | 15.0 (3.0-24.0) | 3.0 (3.0-8.0) | 24.4% | 95.6 | - | - | |
| Sun et al. (2015) | 182 | HCC | 17.8 (3.2-37.0) | 3.7 (3.0-5.0) | 20.3% | 89 | 60 | - | 2.7% |
| Liang et al (2003) | 74 | Mets | 25.1 (5.0-83.0) | 3.1 (0.7-6.8) | 13.3% | 91.4 | 46.4 | 29 | 4.0% |
| Lorentzen et al. (2011) | 39 | Mets | 11.0 (4.0-20.0) | - (0.60-4.0) | 9.6% | - | - | - | 2.5% |
| Liu et al. (2013) | 35 | Mets | 32.2 (-) | 2.3 (0.8-5.0) | 14.5% | 82.4 | 55.8 | 44 | 1.1% |